Your browser is unsupported and may have security vulnerabilities! Upgrade to a newer browser to experience this site in all it's glory.
Skip to main content

From | Wednesday 5 June 2019

Trading update says the acquisition supports strategy to invest in technology to 'further multi-asset digital surgery and robotic ecosystem'.

Smith & Nephew first announced its deal to purchase Brainlab​ in March. Picture: Hull Live

FTSE 100 medical giant Smith & Nephew has completed the acquisition of joint reconstructing business Brainlab.

The Hull-headquartered manufacturer first announced its deal to purchase Brainlab back in March.

The company outlined plans to add Brainlab’s pioneering hip software to its existing NAVIO device – a handheld tool which hopes to reduce surgery times.

On Monday, Smith & Nephew confirmed it had completed the acquisition of Brainlab.

It said in a trading update: “The acquisition supports Smith & Nephew's strategy to invest in best-in-class technologies that further its multi-asset digital surgery and robotic ecosystem."

Read the full story here.